Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 26, 2024
Date Accepted: Jun 14, 2024

The final, peer-reviewed published version of this preprint can be found here:

Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial

Shaffer KM, Reese J, Dressler EV, Glazer JV, Cohn W, Showalter SL, Clayton AH, Danhauer SC, Loch M, Kadi M, Smith C, Weaver KE, Lesser GJ, Ritterband LM

Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial

JMIR Res Protoc 2024;13:e57781

DOI: 10.2196/57781

PMID: 39159450

PMCID: 11369542

Factorial trial to optimize an internet-delivered intervention for sexual health after breast cancer: Protocol for the WF-2202 SHINE trial

  • Kelly M. Shaffer; 
  • Jennifer Reese; 
  • Emily V. Dressler; 
  • Jillian V. Glazer; 
  • Wendy Cohn; 
  • Shayna L. Showalter; 
  • Anita H. Clayton; 
  • Suzanne C. Danhauer; 
  • Michelle Loch; 
  • Mai Kadi; 
  • Caleigh Smith; 
  • Kathryn E. Weaver; 
  • Glenn J. Lesser; 
  • Lee M. Ritterband

ABSTRACT

Background:

Although most breast cancer survivors report significant sexual concerns following treatment, few receive support for these concerns. Delivering sexual health care to breast cancer survivors via the internet could overcome many of the barriers to in-person treatment. Even when delivered remotely, survivor time constraints remain a leading barrier to sexual health intervention uptake.

Objective:

Guided by the Multiphase Optimization Strategy methodological framework, the primary objective of this study is to identify the most efficient internet-delivered sexual health intervention package that is expected to provide breast cancer survivors the greatest benefit with the fewest (and least-intensive) intervention components. Secondarily, this study also aims to determine how intervention components work (i.e., mediators) and for whom they work best (i.e., moderators).

Methods:

Partnered, post-treatment adult female breast cancer survivors (N=320) experiencing at least 1 bothersome sexual symptom (i.e., pain with sex, vaginal dryness, low sexual desire, difficulty with orgasm) related to their breast cancer treatment will be enrolled. Recruitment will be conducted via the Wake Forest National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base. Participants will be randomly assigned to 1 of 16 combinations of 4 intervention components with 2 levels each in this factorial trial: psychoeducation about cancer-related sexual morbidity (receive either enhanced vs. standard versions); communication skills training for discussing concerns with health care providers (receive vs. do not receive); communication skills training for discussing concerns with a partner (receive vs. do not receive); and intimacy promotion skills training (receive vs. do not receive). Cores will be implemented using a robust internet intervention platform with highly-engaging elements like animation, video, and automated email prompts. Survivors will complete online assessments at baseline (pre-randomization) and again at 12- and 24-weeks later. The primary study aim will be achieved through a decision-making process based on systematically evaluating main and interaction effects of components on sexual distress (Female Sexual Distress Scale–Desire, Arousal, Orgasm) and sexual functioning (Female Sexual Functioning Inventory) using a General Linear Model (GLM) approach to ANOVA with effect coding. Mediation analyses will be conducted through a structural equation modeling approach, and moderation analyses will be conducted by extending the GLM models to include interaction effects.

Results:

This protocol has been reviewed and approved by the NCI Central Institutional Review Board and is registered through ClinicalTrials.gov (NCT06216574). Data collection is planned to begin Spring 2024 and conclude in 2027.

Conclusions:

By identifying the combination of the fewest and least-intensive intervention components likely to provide breast cancer survivors the greatest sexual health benefit, this study will result in the first internet intervention optimized for maximum impact on the undertreated, prevalent, and distressing problem of breast cancer-related sexual morbidity. Clinical Trial: ClinicalTrials.gov ID – NCT06216574


 Citation

Please cite as:

Shaffer KM, Reese J, Dressler EV, Glazer JV, Cohn W, Showalter SL, Clayton AH, Danhauer SC, Loch M, Kadi M, Smith C, Weaver KE, Lesser GJ, Ritterband LM

Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial

JMIR Res Protoc 2024;13:e57781

DOI: 10.2196/57781

PMID: 39159450

PMCID: 11369542

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.